We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Sigma Healthcare is a medical distribution business based in Australia. Sigma Healthcare shares (SIG) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Sigma Healthcare has a trailing 12-month revenue of around $3.5 billion. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Long-term investing
| 52-week range | $0.425 - $0.7279 |
|---|---|
| 50-day moving average | $0.4884 |
| 200-day moving average | $0.5856 |
| Target price | $0.56 |
| PE ratio | 8.3036 |
| Dividend yield | $0.02 (4.21%) |
| Earnings per share (TTM) | $0.056 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.47
| 1 week (2022-01-12) | -1.05% |
|---|---|
| 1 month (2021-12-17) | 4.44% |
| 3 months (2021-10-19) | -17.54% |
| 6 months (2021-07-19) | -23.58% |
| 1 year (2021-01-19) | -23.58% |
|---|---|
| 2 years (2020-01-17) | -22.95% |
| 3 years (2019-01-18) | -21.01% |
| 5 years (2017-01-19) | -61.48% |
Valuing Sigma Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sigma Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sigma Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Sigma Healthcare shares trade at around 8x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Sigma Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $56 million (£0.0 million).
The EBITDA is a measure of a Sigma Healthcare's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3.5 billion |
|---|---|
| Operating margin TTM | 1.21% |
| Gross profit TTM | $239.2 million |
| Return on assets TTM | 2.18% |
| Return on equity TTM | 12.95% |
| Profit margin | 1.8% |
| Book value | 0.509 |
| Market capitalisation | $492.6 million |
TTM: trailing 12 months
Dividend payout ratio: 1.57% of net profits
Recently Sigma Healthcare has paid out, on average, around 1.57% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.21% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Sigma Healthcare shareholders could enjoy a 4.21% return on their shares, in the form of dividend payments. In Sigma Healthcare's case, that would currently equate to about A$0.02 per share.
While Sigma Healthcare's payout ratio might seem low, this can signify that Sigma Healthcare is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 23 September 2021 (the "ex-dividend date").
Sigma Healthcare's shares were split on 9 September 2009.
Over the last 12 months, Sigma Healthcare's shares have ranged in value from as little as $0.425 up to $0.7279. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Sigma Healthcare's is -0.1211. This would suggest that Sigma Healthcare's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Sigma Healthcare has bucked the trend.
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale and distribution of pharmaceutical products primarily in Australia. It operates a network of branded and independent stores under the Amcal+, Chemist King, Discount Drug Stores, Guardian, WholeLife, and PharmaSave brands. The company also develops and support a range of private label products. In addition, it provides hospital pharmacy services, including data and programs supporting specialty medication services; dose administration aid and related services to the residential, aged care, and community pharmacy sectors; technology solutions and data analytics; and product development and support services for a range of private and exclusive label products, as well as supplies medical consumables and devices to aged care facilities, hospitals, and clinics. Further, the company provides third party and fourth party logistics services to pharmaceutical manufacturers and other supplier partners. Sigma Healthcare Limited was founded in 1912 and is headquartered in Rowville, Australia.
Designed for big companies, this Amex charge card offers a mix of management tools and perks – including a 100,000 bonus Membership Rewards offer.
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
We tried the viral Milk Makeup Hydro Grip Primer and spoiler alert, it's the bee's knees.
Drac and the Pack are back, like you’ve never seen them before.
A delightful compact vacuum with an unjustifiable price.
A new player enters the Australian sports broadcast market.
The Amazon Echo Buds 2 are a solid addition to your earholes if you’re already integrated in the Alexa ecosystem. But if you’re not, its hard to find anything here that really stands out.
Bottom meets top in the BBL as Perth look to continue their winning ways against the Strikers.
A fun thriller, an epic sci-fi and a dark teen drama are among our top picks this week.
Australia and England meet for an historic Ashes Test in Hobart.
